Nuzenio

How Arcutis Built

How Arcutis Built news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila TimesThe Manila Times · Fri, 07 Aug 2026 20:05:55 GMT 24 New Arcutis Employees Get Stock Awards That Vest Over Four Years - Stock TitanStock Titan · Fri, 07 Aug 2026 20:00:00 GMT Arcutis Biotherapeutics (ARQT) Stock Profit Turn Faces ZORYVE Concentration Question - simplywall.stsimplywall.st · Fri, 07 Aug 2026 04:51:16 GMT Press Release: Arcutis Announces Second Quarter 2026 Financial Results and Provides Business Update - MoomooMoomoo · Wed, 05 Aug 2026 20:00:00 GMT Pediatric Dermatology’s Blind Spot: How Arcutis Built a Drug Pipeline Where the Industry Wouldn’t Look - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 04 Aug 2026 12:08:27 GMT Psilocybin Has Crossed the Evidence Threshold. Clinical Guidelines Have Not. - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 04 Aug 2026 12:08:27 GMT

Timeline

Fri, 07 Aug 2026 20:05:55 GMTArcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Fri, 07 Aug 2026 20:00:00 GMT24 New Arcutis Employees Get Stock Awards That Vest Over Four Years - Stock Titan

Fri, 07 Aug 2026 04:51:16 GMTArcutis Biotherapeutics (ARQT) Stock Profit Turn Faces ZORYVE Concentration Question - simplywall.st

Wed, 05 Aug 2026 20:00:00 GMTPress Release: Arcutis Announces Second Quarter 2026 Financial Results and Provides Business Update - Moomoo

Tue, 04 Aug 2026 12:08:27 GMTPediatric Dermatology’s Blind Spot: How Arcutis Built a Drug Pipeline Where the Industry Wouldn’t Look - The Clinical Trial Vanguard

Tue, 04 Aug 2026 12:08:27 GMTPsilocybin Has Crossed the Evidence Threshold. Clinical Guidelines Have Not. - The Clinical Trial Vanguard

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

The Manila Times3 live mentions The Clinical Trial3 live mentions Arcutis Biotherapeutics Reports2 live mentions Inducement Grants Under2 live mentions Nasdaq Listing Rule2 live mentions New Arcutis Employees2 live mentions Get Stock Awards2 live mentions That Vest Over2 live mentions Arcutis Biotherapeutics2 live mentions ARQT2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for How Arcutis Built.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.